Fortrea Holdings Inc. (FTRE) - Q1 2026 10-Q Summary
Business Context and Reporting Period
Fortrea Holdings Inc. is a global contract research organization (CRO) providing biopharmaceutical and medical device development solutions. The company operates in a single reportable segment, Clinical Services. This report covers the quarterly period ended March 31, 2026. As of May 1, 2026, the company had 94.6 million shares of common stock outstanding.
Key Financial Metrics
| Metric (in millions) | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenues | $636.5 | $651.3 |
| Operating Loss | $(3.4) | $(520.1) |
| Net Loss | $(23.6) | $(562.9) |
| Diluted EPS | $(0.25) | $(6.25) |
| Operating Cash Flow | $(17.0) | $(124.2) |
| Cash and Equivalents | $147.5 | $101.6 |
| Total Debt (Current + Long-term) | $1,053.5 | $1,052.8 |
| Backlog | $7.8 billion | N/A |
Note: Total Debt calculated as Current portion of long-term debt ($10.9M) + Long-term debt ($1,042.6M).
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 2.3% year-over-year to $636.5 million, driven by a 3.2% decrease in organic revenue due to lower pass-through costs and reduced demand for functional service provider business, partially offset by a 0.9% favorable foreign currency impact.
- Significant Profitability Improvement: Operating loss narrowed dramatically from $520.1 million in Q1 2025 to $3.4 million in Q1 2026. This improvement is primarily attributable to the absence of the $488.8 million goodwill impairment recorded in Q1 2025.
- Cost Reductions: Direct costs decreased 4.1% to $512.9 million, and SG&A expenses dropped 17.5% to $100.5 million, reflecting lower personnel costs, restructuring benefits, and reduced IT expenses.
- Cash Flow Recovery: Net cash used in operating activities improved significantly to $17.0 million from $124.2 million used in the prior year, aided by better collections on accounts receivable.
Outlook, Risks, and Unusual Items
- Restructuring: The company recorded $6.7 million in restructuring and other charges, primarily for severance benefits. The restructuring liability balance stands at $11.3 million as of March 31, 2026.
- Legal Proceedings: A shareholder class action lawsuit (Lucas Deslande v. Fortrea Holdings Inc.) was filed in June 2025 alleging securities law violations. The company filed a motion to dismiss in January 2026; the case is in early stages, and no loss estimate can be made.
- Debt and Liquidity: The company has $447.7 million available under its revolving credit facility. It amended its $300 million receivables securitization program in February 2026, extending the termination date to February 2029.
- Tax Impact: The effective tax rate was (91.9)% for Q1 2026, impacted by valuation allowances and non-deductible compensation, compared to (2.7)% in Q1 2025 which was heavily influenced by the non-deductible goodwill impairment.
- Stockholder Rights Plan: A rights plan adopted in June 2025 is in effect, expiring June 10, 2026, designed to deter hostile takeovers.
Investor Verification Checklist
- Goodwill Impairment Recurrence: Verify if the $488.8 million impairment in Q1 2025 was a one-time event or if current market conditions pose a risk of future impairments.
- Organic Revenue Trends: Confirm the sustainability of the 3.2% organic revenue decline and the specific drivers behind lower demand for functional service provider business.
- Customer Concentration: Review the impact of the top customer, which accounted for 17.2% of Q1 2026 revenues and 18.5% of gross accounts receivable.
- Legal Exposure: Monitor the status of the Lucas Deslande class action lawsuit for potential settlement costs or reputational damage.
- Debt Covenants: Ensure continued compliance with net leverage and interest coverage ratios, particularly given the company's accumulated deficit of $1.4 billion.